PRE 14A

PRELIMINARY PROXY STATEMENT

Company: ORAMED PHARMACEUTICALS INC.
Filed: June 16, 2020
Period of Report: June 16, 2020
Accession Number: 0001213900-20-015109

View Document ↗ View on SEC.gov ↗